Veterans’ RightsAn independent resource for veterans
← All decisions
Granted

The reduction in the rating for prostate cancer from 100 percent to 20 percent, effective October 1, 2013, was proper as there is no evidence of local reoccurrence or metastasis.

The deciding factor: The Veteran's PSA levels were undetectable within the past year and he was found to be in remission. The March 2012 VA examination report documented his well-being with no evidence of recurrent prostate cancer.

Claimed conditions
adenocarcinoma of the prostate, erectile dysfunction
How they argued it
Direct service connection
Exposure basis
None
Rating assigned
20%
Decision date
December 14, 2018
Citation
18158130

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation 18158130.

What this means for you

A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.

What you can do next

Related decisions

Other Board decisions on a similar condition or argued the same way.

Free starter guide for your own claim

Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.

We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.

We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.

This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.